Login
← Go Back
Alivus Life Sciences
ALIVUS · Pharma > Pharmaceuticals & Drugs · Chairman: Glenn Saldanha · MD: Yasir Rawjee · Listing date: Aug. 7, 2021 · Employees: 1537 · Mumbai · http://www.glenmarklifesciences.com
Stock Price vs Company Growth
1d
0.4%
1w
0.6%
1m
23.4%
3m
32.1%
6m
54.7%
1y
46.9%
5y
17.3%
all
16.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,399 0.4%
996
1,416
Company Overview
Sales
2,590 Cr
Growth: 6.8%
Profit after Tax
603 Cr
Growth: 6.8%
Mid Cap
17,176 Cr
P/E: 28.5x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 2,590
Growth 6.8%
EBITDA 32.3%
P/S 6.6x
Dividend 0.5%
P/E 28.5x
Book Value ₹ 284
PEG Ratio 4.2x
ROE 18.4%
P/B 4.9x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is in the business of making high-quality drugs by unlocking the possibilities of science.Awards, accreditations and recognitions2015: Ankleshwar plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Dahej plant received ISO 14001:2015 certifying the management system of manufacturing facility.2016: Ankleshwar plant received BS OHSAS 18001:2017 certifying the management system of the manufacturing facility.
Belongs to (14 Indices) view more
Investors (7)
santhosh...
nirma
ramesh72
Followers (2)
atharav
varsha96